MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [ChIP-Seq]. Homo sapiens
收藏NIAID Data Ecosystem2026-03-09 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA321295
下载链接
链接失效反馈官方服务：
资源简介：
MEIS2 collaborates with AML1-ETO in inducing acute myeloid leukemia in a murine bone marrow transplantation model Overall design: We employed ChIP-seq to assess the impact of MEIS2 knockdown on the DNA binding profile of AML1-ETO (Kasumi-1 cell line)
创建时间：
2016-05-11
